Upgrade to SI Premium - Free Trial

Blend Announces Fourth Quarter and Full Year 2024 Financial Results

February 27, 2025 4:05 PM

Welcomes Major New Customers; Achieves Strong Revenue Through Difficult Macro

SAN FRANCISCO--(BUSINESS WIRE)-- Blend Labs, Inc. (NYSE: BLND), a leading origination platform for digital banking solutions, today announced its fourth quarter and full year 2024 financial results.

“2024 was a pivotal year for Blend. In Q4, we brought on several new customers, including PHH Mortgage and a top 10 U.S. bank,” said Nima Ghamsari, Head of Blend. “We achieved 42% annual revenue growth in our Consumer Banking business, reinforcing its promise as an emerging growth driver. At the same time, we made significant strides in simplifying Blend and sharpening our focus on a pure software model. We expanded high margin partnerships in homeowners insurance and income verification, and are now finalizing a similar approach in title insurance. These efforts have led us to our most profitable quarter yet, and sets us up to fully focus on our core mission––delivering frictionless origination software for our customers.”

Recent Highlights

Fourth Quarter 2024 Financial Highlights

Revenue

Gross Margin & Profitability

Liquidity, Cash, & Capital Resources

Full Year 2024 Financial Highlights

Revenue

Gross Margin & Profitability

Liquidity, Cash, & Capital Resources

First Quarter 2025 Outlook

Blend is providing guidance for the first quarter of 2025 as follows:

$ in millions

Q1 2025 Guidance

Blend Platform Segment Revenue

$25.0 – $27.0

Blend Platform Non-GAAP Net Operating Income

($1.0) – $1.0

Blend's 1Q25 guidance reflects our expectation that U.S. aggregate industry mortgage originations will be lower in 1Q25 relative to 4Q24 based on application volume observed to date through our customer base and our analysis of the latest relevant macroeconomic data, including our view of the mortgage market size. We view the mortgage market size based on the Home Mortgage Disclosure Act (“HMDA”) data as previously disclosed in our 3Q24 earnings materials, and for 1Q25 we expect that market size to be between 800,000 and 900,000 units. Additionally, it incorporates the expected impact of our strategic partnerships and expansion of our platform strategy.

Full Year 2025 Outlook

Blend is providing guidance for the full year of 2025 as follows:

FY 2025 Guidance

Consumer Banking Suite Revenue 2023 to 2026 CAGR

Increasing from 35% to 40%

Note that economic conditions, including those affecting the levels of real estate and mortgage activity, as well as the financial condition of some of our financial customers, remain highly uncertain.

We have not provided the forward-looking GAAP equivalent to our non-GAAP Net Operating Income outlook, or a GAAP reconciliation as a result of the uncertainty regarding, and the potential variability of, stock-based compensation, which is affected by our hiring and retention needs and future prices of our stock, and non-recurring, infrequent or unusual items.

We have not provided the forward-looking GAAP equivalent to our non-GAAP Free Cash Flow Margin, or a GAAP reconciliation as a result of the uncertainty regarding, and the potential variability of, internal use software development costs that qualify for capitalization, which is affected by the projects prioritized during the reporting period.

Webcast Information

On Thursday, February 27, 2025 at 4:30 pm ET, Blend will host a live discussion of its fourth quarter and full year 2024 financial results. A link to the live discussion will be made available on the Company’s investor relations website at https://investor.blend.com. A replay will also be made available following the discussion at the same website.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, quotations of management; the “First Quarter and Full Year 2025 Outlook” section above; Blend’s expectations regarding its financial condition and operating performance, including growth opportunities, investments and plans for future operations and competitive position; Blend’s partnerships and expectations related to such partnerships on Blend’s products and business; Blend’s products, pipeline, and technologies; Blend’s customers and customer relationships, including the businesses of such customers and their position in the market; Blend’s cost reduction efforts and ability to achieve or maintain profitability in the future; projections for mortgage loan origination volumes, including projections provided by third parties; other macroeconomic and industry conditions; and Blend’s expectations for changes in revenue, as well as assumptions relating to the foregoing. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “would,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other comparable terminology that concern Blend’s expectations, strategy, plans or intentions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which such performance or results will be achieved, if at all.

Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith beliefs and assumptions as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. These risks and uncertainties include the risks that: changes in economic conditions, such as mortgage interest rates, credit availability, real estate prices, inflation or consumer confidence, adversely affect our industry, markets and business, we fail to retain our existing customers or to acquire new customers in a cost-effective manner; our customers fail to maintain their utilization of our products and services; our relationships with any of our key customers were to be terminated or the level of business with them significantly reduced over time; we are unable to compete in highly competitive markets; we are unable to manage our growth; we are unable to make accurate predictions about our future performance due to our limited operating history in an evolving industry and evolving markets; our restructuring actions do not result in the desired outcomes or adversely affect our business, impairment charges on certain assets have an adverse effect on our financial condition and results of operations; risks related to the investment from Haveli, including the governance rights of Haveli and potential dilution as a result of the investment; changes to our expectations regarding our share repurchase program; or we are unable to generate sufficient cash flows or otherwise maintain sufficient liquidity to fund our operations and satisfy our liabilities. Further information on these risks and other factors that could affect our financial results are set forth in our filings with the Securities and Exchange Commission, including in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and our Annual Report on Form 10-K for the year ended December 31, 2024 that will be filed following this press release. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. These factors could cause actual results, performance, or achievement to differ materially and adversely from those anticipated or implied in the forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release. Except as required by law, Blend does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

About Non-GAAP Financial Measures and Other Performance Metrics

In addition to financial measures prepared in accordance with GAAP, this press release and the accompanying tables contain, and the conference call will contain, non-GAAP financial measures, including non-GAAP gross profit and non-GAAP gross profit margin, non-GAAP software platform gross profit and gross margin, non-GAAP Blend Platform segment gross profit and gross margin, non-GAAP operating expenses, non-GAAP income (loss) from operations, non-GAAP operating margin, non-GAAP net operating income (loss), and non-GAAP diluted net income (loss) per share attributable to common stockholders. Our management uses these non-GAAP financial measures internally in analyzing our financial results and believes they are useful to investors, as a supplement to the corresponding GAAP financial measures, in evaluating our ongoing operational performance and trends, in allowing for greater transparency with respect to measures used by our management in their financial and operational decision making, and in comparing our results of operations with other companies in the same industry, many of which present similar non-GAAP financial measures to help investors understand the operational performance of their businesses.

We adjust the following items from our non-GAAP financial measures as detailed in the reconciliations below:

Stock-based compensation. We exclude stock-based compensation, which is a non-cash expense, from our non-GAAP financial measures because we believe that excluding this cost provides meaningful supplemental information regarding operational performance. In particular, companies calculate stock-based compensation expense using a variety of valuation methodologies and subjective assumptions, and expense related to stock-based awards can vary significantly based on the timing, size and nature of awards granted.

Workforce reduction costs. We exclude restructuring costs related to workforce reductions as these costs primarily include employee severance, executive transition costs and other costs directly associated with resource realignments incurred in connection with changing strategies or business conditions. These costs can vary significantly in amount and frequency based on the nature of the actions as well as the changing needs of our business and we believe that excluding them provides easier comparability of pre- and post-restructuring operating results.

Abandoned and terminated facilities costs. In the third quarter of 2024, we abandoned our headquarters in San Francisco, California and early terminated our office lease in Omaha. We exclude costs related to abandoned and terminated leases as these costs related to a one-time strategic business decision, are non-recurring or short-term in nature and are not reflective of our ongoing operations. Thus we believe that excluding these charges for purposes of calculating the non-GAAP financial measures provides more meaningful period to period comparisons.

Compensation realignment costs. We exclude the compensation realignment costs incurred in connection with the change in our compensation strategy from our non-GAAP financial measures. These costs relate to amortization of one-time two-installment cash bonus payment made to certain employees in lieu of previously committed equity-based awards, driven by an organizational initiative to standardize our equity compensation program. We believe that excluding these charges for purposes of calculating the non-GAAP financial measures provides more meaningful period to period comparisons.

Litigation contingencies. We exclude costs related to litigation contingencies, which represent reserves for legal settlements. These costs are non-recurring in nature and we do not believe they have a direct correlation to the operation of our business.

Transaction-related costs. We exclude costs related to mergers and acquisitions from our non-GAAP financial measures as we do not consider these costs to be related to organic continuing operations of the acquired business or relevant to assessing the long-term performance of the acquired assets. These adjustments allow for more accurate comparisons of the financial results to historical operations and forward looking guidance. These costs include financial advisory, legal, accounting and other transactional costs incurred in connection with acquisition activities, and non-recurring transition and integration costs.

Loss on extinguishment of debt. We exclude the write offs of unamortized debt issuance costs and debt discounts related to the extinguishment of our term loan and termination of the credit agreement from our non-GAAP financial measures. These costs are non-recurring in nature and we do not believe they have a direct correlation to the operation of our business.

Gain on sale of insurance business. We exclude the gain on sale of our insurance business to a third party, which is comprised of the excess consideration received for the net assets transferred as part of the sale agreement. This gain is non-recurring in nature and we do not believe it has a direct correlation to the operation of our business.

Amortization of capitalized internal-use software. We exclude the amortization of capitalized internal-use software because we do not believe this non-cash expense has a direct correlation to the operation of our business.

Gain on investment in equity securities. We exclude gains related to the carrying value adjustments of non-marketable equity securities because we do not believe these non-cash gains have a direct correlation to the operation of our business.

Foreign currency gains and losses. We exclude unrealized gains and losses resulting from remeasurement of assets and liabilities from foreign currency into the functional currency as we do not believe these gains and losses to be indicative of our business performance and excluding these gains and losses provides information consistent with how we evaluate our operating results.

Loss on transfer of subsidiary. We exclude loss on transfer of our subsidiary in India to a third party, which is primarily comprised of impairment charges related to certain assets transferred as part of the agreement, costs incurred to settle certain liabilities arising from the agreement, and one-time legal costs incurred to facilitate the transaction. These costs are non-recurring in nature and we do not believe they have a direct correlation to the operation of our business.

Changes in non-GAAP EPS metric. We have historically reported non-GAAP basic (consolidated) net loss per share as our earnings per share metric, as we believed the metric was most appropriate in light of our ongoing net losses. As our business has evolved and we maintained non-GAAP net income during the three months ended December 31, 2024, we no longer view non-GAAP basic (consolidated) net loss per share as useful or appropriate to understanding our earnings per share metric. Therefore we are no longer using basic (consolidated) net loss per share in calculating our earnings per share. Instead, we will be disclosing non-GAAP diluted net income (loss) per share attributable to common stockholders. The historical periods presented herein have been recast to the updated metric for purposes of comparability.

Our non-GAAP financial measures also include non-GAAP operating margin, which is defined as non-GAAP income (loss) from operations divided by total revenue. We believe that the presentation of non-GAAP operating margin provides useful information to investors as it is one of the metrics we use to assess our operating and financial performance, and also may be a useful metric for investors to compare our operating and financial results with other companies in our industry.

In addition, our non-GAAP financial measures include the following measures related to our liquidity: free cash flow, unlevered free cash flow and free cash flow margin. Free cash flow is defined as net cash flow from operating activities less cash spent on additions to property, equipment, internal-use software and intangible assets. Unlevered free cash flow is defined as free cash flow before cash paid for interest on our outstanding debt. Free cash flow margin is defined as free cash flow divided by total revenue. We believe information regarding free cash flow, free cash flow margin and unlevered free cash flow provide useful information to investors as a basis for comparing our performance with other companies in our industry and as a measurement of the cash generation that is available to invest in our business and meet our financing needs. However, given our debt service obligations and other contractual obligations, unlevered free cash flow does not represent residual cash flow available for discretionary expenditures. In April 2024, we repaid in full all amounts outstanding and payable under our debt obligations and therefore eliminated any debt service obligations.

We have not separately adjusted for certain tax-related impacts of our non-GAAP financial measures, as they are not material to our overall non-GAAP results for the periods presented.

It is important to note that the particular items we exclude from, or include in, our non-GAAP financial measures may differ from the items excluded from, or included in, similar non-GAAP financial measures used by other companies in the same industry. In addition, other companies may utilize metrics that are not similar to ours.

The non-GAAP financial information is presented for supplemental informational purposes only and is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. There are material limitations associated with the use of non-GAAP financial measures since they exclude significant expenses and income that are required by GAAP to be recorded in our financial statements. Please see the reconciliation tables at the end of this release for the reconciliation of GAAP and non-GAAP results. Management encourages investors and others to review Blend’s financial information in its entirety and not rely on a single financial measure.

Economic Value per Funded Loan in our Mortgage Suite represents the contractual rates for mortgage and mortgage-related products multiplied by the number of loans funded or transactions completed, as applicable, by a customer in the specified period, divided by the total number of loans funded by all Mortgage Suite customers in that same period. Additionally, the value derived from partnerships and verification of income products that is associated with the mortgage application stage is aligned with the timing of funding the related loan (typically a 3 month delay from the time of application). We use Economic Value per Funded Loan to measure our success at broadening the client relationships from the underlying mortgage transactions and selling additional products through our software platform.

About Blend

Blend Labs, Inc., (NYSE: BLND) is a leading origination platform for digital banking solutions. Financial providers— from large banks, fintechs, and credit unions to community and independent mortgage banks—use Blend’s platform to transform banking experiences for their customers. Better banking starts on Blend. To learn more, visit blend.com.

Blend Labs, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

December 31, 2024

December 31, 2023

Assets

Current assets:

Cash and cash equivalents

$

42,243

$

30,962

Marketable securities and other investments

56,233

105,960

Trade and other receivables, net of allowance for credit losses of $80 and $149, respectively

17,365

18,345

Prepaid expenses and other current assets

19,329

14,569

Total current assets

135,170

169,836

Property and equipment, net

12,321

3,945

Operating lease right-of-use assets

1,469

8,565

Intangible assets, net

2,081

2,108

Deferred contract costs

2,868

2,453

Other non-current assets

24,103

19,158

Total assets

$

178,012

$

206,065

Liabilities, redeemable equity and stockholders’ equity

Current liabilities:

Accounts payable

$

2,417

$

2,170

Deferred revenue

19,240

8,984

Accrued compensation

3,976

5,562

Other current liabilities

13,316

14,858

Total current liabilities

38,949

31,574

Operating lease liabilities, non-current

801

6,982

Other non-current liabilities

580

2,228

Debt, non-current, net

138,334

Total liabilities

40,330

179,118

Commitments and contingencies

Redeemable noncontrolling interest

52,375

46,190

Series A redeemable convertible preferred stock, par value $0.00001 per share: 200,000 shares authorized as of December 31, 2024 and 2023, 150 and 0 shares issued and outstanding as of December 31, 2024 and 2023, respectively

141,663

Stockholders’ equity:

Class A, Class B and Class C Common Stock, par value $0.00001 per share: 3,000,000 (Class A 1,800,000, Class B 600,000, Class C 600,000) shares authorized as of December 31, 2024 and 2023; 258,173 (Class A 254,426, Class B 3,747, Class C 0) and 249,910 (Class A 240,262, Class B 9,648, Class C 0) shares issued and outstanding as of December 31, 2024 and 2023, respectively

2

2

Additional paid-in capital

1,328,015

1,321,944

Accumulated other comprehensive loss

602

441

Accumulated deficit

(1,384,975

)

(1,341,630

)

Total stockholders’ equity

(56,356

)

(19,243

)

Total liabilities, redeemable equity and stockholders’ equity

$

178,012

$

206,065

Blend Labs, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended
December 31,

Year Ended
December 31,

2024

2023

2024

2023

Revenue

Software platform

$

27,637

$

23,614

$

106,914

$

101,204

Professional services

2,485

2,258

8,848

8,345

Title

11,286

10,232

46,257

47,297

Total revenue

41,408

36,104

162,019

156,846

Cost of revenue

Software platform

5,964

5,061

23,107

22,025

Professional services

1,820

2,617

9,434

11,065

Title

8,895

8,700

38,934

42,621

Total cost of revenue

16,679

16,378

71,475

75,711

Gross profit

24,729

19,726

90,544

81,135

Operating expenses:

Research and development

8,861

14,417

46,087

81,591

Sales and marketing

6,581

11,940

36,049

60,130

General and administrative

10,958

14,542

50,557

70,688

Restructuring

116

694

7,471

24,948

Total operating expenses

26,516

41,593

140,164

237,357

Loss from operations

(1,787

)

(21,867

)

(49,620

)

(156,222

)

Interest expense

(7,085

)

(6,747

)

(30,811

)

Other income (expense), net

1,105

(1,498

)

13,057

7,248

Loss before income taxes

(682

)

(30,450

)

(43,310

)

(179,785

)

Income tax (expense) benefit

(26

)

74

(109

)

(94

)

Net loss

(708

)

(30,376

)

(43,419

)

(179,879

)

Less: Net (income) loss attributable to noncontrolling interest

(117

)

91

74

1,186

Net loss attributable to Blend Labs, Inc.

(825

)

(30,285

)

(43,345

)

(178,693

)

Less: Accretion of redeemable noncontrolling interest to redemption value

(1,511

)

(1,527

)

(6,259

)

(6,627

)

Less: Accretion of Series A redeemable convertible preferred stock to redemption value

(4,170

)

(10,879

)

Net loss attributable to Blend Labs, Inc. common stockholders

$

(6,506

)

$

(31,812

)

$

(60,483

)

$

(185,320

)

Net loss per share attributable to Blend Labs, Inc. common stockholders:

Basic and diluted

$

(0.03

)

$

(0.13

)

$

(0.24

)

$

(0.76

)

Weighted average shares used in calculating net loss per share:

Basic and diluted

256,735

248,616

253,921

245,206

Comprehensive loss:

Net loss

$

(708

)

$

(30,376

)

$

(43,419

)

$

(179,879

)

Unrealized (loss) gain on marketable securities

(215

)

801

87

1,030

Foreign currency translation gain

52

42

74

119

Comprehensive loss

(871

)

(29,533

)

(43,258

)

(178,730

)

Less: Comprehensive (gain) loss attributable to noncontrolling interest

(117

)

91

74

1,186

Comprehensive loss attributable to Blend Labs, Inc.

$

(988

)

$

(29,442

)

$

(43,184

)

$

(177,544

)

Blend Labs, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Three Months Ended
December 31,

Year Ended
December 31,

2024

2023

2024

2023

Operating activities

Net loss

$

(708

)

$

(30,376

)

$

(43,419

)

$

(179,879

)

Adjustments to reconcile net loss to net cash used in operating activities:

Stock-based compensation

6,064

6,223

28,077

46,021

Depreciation and amortization

486

608

2,289

2,464

Amortization of deferred contract costs

289

552

1,068

2,979

Amortization of debt discount and issuance costs

689

690

2,968

Amortization of operating lease right-of-use assets

196

846

2,530

3,296

Accelerated amortization of right-of-use asset in connection with lease abandonment

2,992

Gain on investment in equity securities

(4,417

)

Loss on extinguishment of debt

3,970

5,476

3,970

Gain on sale of insurance business

(9,213

)

Other

(324

)

(530

)

(1,009

)

(5,187

)

Changes in operating assets and liabilities:

Trade and other receivables

(1,476

)

1,245

918

4,274

Prepaid expenses and other assets, current and non-current

(857

)

3,544

(1,060

)

2,048

Deferred contract costs, non-current

(805

)

(220

)

(415

)

(762

)

Accounts payable

554

49

(67

)

910

Deferred revenue

(617

)

(1,072

)

10,256

289

Accrued compensation

(2,405

)

(4,305

)

(1,959

)

(4,497

)

Operating lease liabilities

(1,393

)

(1,068

)

(4,585

)

(4,012

)

Other liabilities, current and non-current

(3,590

)

(846

)

(1,196

)

(2,503

)

Net cash used in operating activities

(4,586

)

(20,691

)

(13,044

)

(127,621

)

Investing activities

Purchases of marketable securities

(5,608

)

(32,798

)

(102,030

)

(236,079

)

Sale of available-for-sale securities

55,822

100,327

56,022

Maturities of marketable securities

11,300

32,795

53,150

310,450

Additions to property, equipment and internal-use software development costs

(2,581

)

(82

)

(9,844

)

(587

)

Other

(283

)

Proceeds from sale of insurance business

9,075

Investment in note receivable

(5,000

)

(2,500

)

(5,000

)

(2,500

)

Net cash (used in) provided by investing activities

(1,889

)

53,237

45,395

127,306

Financing activities

Proceeds from exercises of stock options, including early exercises, net of repurchases

789

248

1,658

268

Taxes paid related to net share settlement of equity awards

(7,112

)

(1,314

)

(18,115

)

(6,171

)

Repayment of long-term debt

(85,055

)

(144,500

)

(85,055

)

Net proceeds from the issuance of the Series A redeemable convertible preferred stock and the Haveli Warrant

149,375

Payment for issuance costs related to the Series A redeemable convertible preferred stock and the Haveli Warrant

(9,480

)

Net cash used in financing activities

(6,323

)

(86,121

)

(21,062

)

(90,958

)

Effect of exchange rates on cash, cash equivalents, and restricted cash

(21

)

(5

)

(31

)

Net increase (decrease) in cash, cash equivalents, and restricted cash

(12,798

)

(53,596

)

11,284

(91,304

)

Cash, cash equivalents, and restricted cash at beginning of period

62,335

91,849

38,253

129,557

Cash, cash equivalents, and restricted cash at end of period

$

49,537

$

38,253

$

49,537

$

38,253

Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets:

Cash and cash equivalents

$

42,243

$

30,962

$

42,243

$

30,962

Restricted cash

7,294

7,291

7,294

7,291

Total cash, cash equivalents, and restricted cash

$

49,537

$

38,253

$

49,537

$

38,253

Supplemental disclosure of cash flow information:

Cash paid for income taxes

$

$

59

$

76

$

107

Cash paid for interest

$

$

6,350

$

6,150

$

27,814

Supplemental disclosure of non-cash investing and financing activities:

Vesting of early exercised stock options

$

$

202

$

363

$

1,446

Operating lease liabilities arising from obtaining new or modified right-of-use assets

$

$

$

1,151

$

327

Stock-based compensation included in capitalized internal-use software development costs

$

509

$

$

2,450

$

Accretion of redeemable noncontrolling interest to redemption value

$

1,511

$

1,527

$

6,259

$

6,627

Accretion of Series A redeemable convertible preferred stock to redemption value

$

4,170

$

$

10,879

$

Covered Warrant received in connection with strategic partnership and sale of insurance business

$

$

$

222

$

Capitalized internal-use software development costs included in accrued compensation

$

155

$

$

155

$

Blend Labs, Inc.

Revenue Disaggregation

(In thousands)

(Unaudited)

Three Months Ended December 31,

2024

2023

Blend Platform:

YoY change

Mortgage Suite

$

18,179

61

%

$

17,203

66

%

6

%

Consumer Banking Suite

9,458

31

%

6,411

25

%

48

%

Total software platform

27,637

92

%

23,614

91

%

17

%

Professional services

2,485

8

%

2,258

9

%

10

%

Total Blend Platform

30,122

100

%

25,872

100

%

16

%

Title

11,286

10,232

10

%

Total revenue

$

41,408

$

36,104

15

%

Year Ended December 31,

2024

2023

Blend Platform:

YoY change

Mortgage Suite

$

73,257

63

%

$

77,574

70

%

(6

)%

Consumer Banking Suite

33,657

29

%

23,630

22

%

42

%

Total software platform

106,914

92

%

101,204

92

%

6

%

Professional services

8,848

8

%

8,345

8

%

6

%

Total Blend Platform

115,762

100

%

109,549

100

%

6

%

Title

46,257

47,297

(2

)%

Total revenue

$

162,019

$

156,846

3

%

Blend Labs, Inc.

Reconciliation of GAAP to non-GAAP Measures

(In thousands)

(Unaudited)

Three Months Ended December 31, 2024

GAAP

Non-GAAP adjustments

Non-GAAP

Gross

Profit

Gross Margin

Stock-based compensation(1)

Amortization of capitalized internal-use software(9)

Gross

Profit

Gross Margin

Blend Platform

Software platform

$

21,673

78

%

$

3

$

249

$

21,925

79

%

Professional services

665

27

%

142

807

32

%

Total Blend Platform

22,338

74

%

145

249

22,732

75

%

Title

2,391

21

%

1

2,392

21

%

Total

$

24,729

60

%

$

146

$

249

$

25,124

61

%

Three Months Ended December 31, 2023

GAAP

Non-GAAP adjustments

Non-GAAP

Gross

Profit

Gross Margin

Stock-based compensation(1)

Amortization of capitalized internal-use software(9)

Gross

Profit

Gross Margin

Blend Platform

Software platform

$

18,553

79

%

$

6

$

$

18,559

79

%

Professional services

(359

)

(16

)%

147

(212

)

(9

)%

Total Blend Platform

18,194

70

%

153

18,347

71

%

Title

1,532

15

%

1,532

15

%

Total

$

19,726

55

%

$

153

$

$

19,879

55

%

Year Ended December 31, 2024

GAAP

Non-GAAP adjustments

Non-GAAP

Gross

Profit

Gross Margin

Stock-based compensation(1)

Amortization of capitalized internal-use software(9)

Gross

Profit

Gross Margin

Blend Platform

Software platform

$

83,807

78

%

$

13

$

491

$

84,311

79

%

Professional services

(586

)

(7

)%

497

(89

)

(1

)%

Total Blend Platform

83,221

72

%

510

491

84,222

73

%

Title

7,323

16

%

17

7,340

16

%

Total

$

90,544

56

%

$

527

$

491

$

91,562

57

%

Year Ended December 31, 2023

GAAP

Non-GAAP adjustments

Non-GAAP

Gross

Profit

Gross Margin

Stock-based compensation(1)

Amortization of capitalized internal-use software(9)

Gross

Profit

Gross Margin

Blend Platform

Software platform

$

79,179

78

%

$

36

$

$

79,215

78

%

Professional services

(2,720

)

(33

)%

950

(1,770

)

(21

)%

Total Blend Platform

76,459

70

%

986

77,445

71

%

Title

4,676

10

%

146

4,822

10

%

Total

$

81,135

52

%

$

1,132

$

$

82,267

52

%

Blend Labs, Inc.

Reconciliation of GAAP to non-GAAP Measures

(In thousands)

(Unaudited)

Three Months Ended
December 31,

Year Ended
December 31,

2024

2023

2024

2023

GAAP operating expenses

$

26,516

$

41,593

$

140,164

$

237,357

Non-GAAP adjustments:

Stock-based compensation(1)

5,919

6,070

27,550

44,889

Workforce reduction costs(2)

116

694

2,987

24,948

Abandoned and terminated facilities costs(3)

537

5,021

Compensation realignment costs(4)

1,011

1,155

5,174

Litigation contingencies(5)

650

303

405

Transaction-related costs(6)

175

2,066

Non-GAAP operating expenses

$

19,944

$

32,993

$

103,148

$

159,875

GAAP loss from operations

$

(1,787

)

$

(21,867

)

$

(49,620

)

$

(156,222

)

Non-GAAP adjustments:

Stock-based compensation(1)

6,064

6,223

28,077

46,021

Workforce reduction costs(2)

116

694

2,987

24,948

Abandoned and terminated facilities costs(3)

537

5,021

Amortization of capitalized internal-use software(9)

249

491

Compensation realignment costs(4)

1,011

1,155

5,174

Litigation contingencies(5)

650

303

405

Transaction-related costs(6)

175

2,066

Non-GAAP income (loss) from operations

$

5,179

$

(13,114

)

$

(11,586

)

$

(77,608

)

GAAP operating margin

(4

)%

(61

)%

(31

)%

(100

)%

Non-GAAP operating margin

13

%

(36

)%

(7

)%

(49

)%

GAAP net loss

$

(708

)

$

(30,376

)

$

(43,419

)

$

(179,879

)

Non-GAAP adjustments:

Stock-based compensation(1)

6,064

6,223

28,077

46,021

Loss on extinguishment of debt(7)

3,970

5,531

3,970

Workforce reduction costs(2)

116

694

2,987

24,948

Abandoned and terminated facilities costs(3)

537

5,021

Gain on sale of insurance business(8)

(9,239

)

Amortization of capitalized internal-use software(9)

249

491

Compensation realignment costs(4)

1,011

1,155

5,174

Litigation contingencies(5)

650

303

405

Transaction-related costs(6)

175

2,066

Gain on investment in equity securities(10)

(4,417

)

Foreign currency gains and losses(11)

97

6

117

(77

)

Loss on transfer of subsidiary(12)

601

Non-GAAP net income (loss)

$

6,355

$

(17,647

)

$

(12,792

)

$

(97,372

)

Blend Labs, Inc.

Reconciliation of GAAP to non-GAAP Measures

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended
December 31,

Year Ended
December 31,

2024

2023

2024

2023

GAAP diluted net loss per share attributable to common stockholders

$

(0.03

)

$

(0.13

)

$

(0.24

)

$

(0.76

)

Per share impact of non-GAAP Expenses(13)

(0.03

)

(0.05

)

(0.12

)

(0.34

)

Non-GAAP diluted income (loss) per share attributable to common stockholders

$

0.00

$

(0.08

)

$

(0.12

)

$

(0.42

)

GAAP diluted weighted average shares used in calculating net loss per share

256,735

248,616

253,921

245,206

Non-GAAP diluted weighted average shares used in calculating net income (loss) per share

274,208

248,616

253,921

245,206

Three Months Ended
December 31,

Year Ended
December 31,

2024

2023

2024

2023

Net cash provided used in operating activities

$

(4,586

)

$

(20,691

)

$

(13,044

)

$

(127,621

)

Additions to property, equipment and internal-use software development costs

(2,581

)

(82

)

(9,844

)

(587

)

Free cash flow

(7,167

)

(20,773

)

(22,888

)

(128,208

)

Cash paid for interest

6,350

6,150

27,814

Unlevered free cash flow

$

(7,167

)

$

(14,423

)

$

(16,738

)

$

(100,394

)

Revenue

$

41,408

$

36,104

$

162,019

$

156,846

Free cash flow margin

(17

)%

(58

)%

(14

)%

(82

)%

Notes:

(1) Stock-based compensation represents the non-cash grant date fair value of stock-based instruments utilized to incentivize our employees, for which the expense is recognized over the applicable vesting or performance period.

Three Months Ended
December 31,

Year Ended
December 31,

Stock-based compensation by function:

2024

2023

2024

2023

Cost of revenue

$

145

$

153

$

527

$

1,132

Research and development *

1,782

1,996

9,870

19,046

Sales and marketing

831

846

3,546

7,137

General and administrative

3,306

3,228

14,134

18,706

Total

$

6,064

$

6,223

$

28,077

$

46,021

* Net of $0.6 million and $2.5 million of additions to capitalized internal-use software for the three and twelve months ended December 31, 2024 and none for the three and twelve months ended December 31, 2023

(2) Workforce reduction costs represent expenses incurred in connection with the workforce restructuring actions executed as part of our broader efforts to improve cost efficiency.

(3) Abandoned and terminated facilities costs represent charges related to the early termination of a leased facility and abandonment of another leased facility as part of our broader efforts to better align our operating structure with our business activities.

(4) Compensation realignment costs relate to amortization of one-time cash bonus payment (paid in two installments in March and May 2023) to certain employees in lieu of previously committed equity-based awards, driven by an organizational initiative to standardize our equity compensation program.

(5) Litigation contingencies represent reserves for legal settlements that are unusual or infrequent costs associated with our operating activities.

(6) Transaction-related costs include non-recurring due diligence, consulting, and integration costs recorded within general and administrative expense.

(7) Loss on extinguishment of debt represents a write off of unamortized debt issuance costs and debt discounts related to the extinguishment of our term loan.

(8) Gain on sale of insurance business represents the gain recognized in connection with the sale of certain assets of our insurance agency, partially offset by transaction costs.

(9) Amortization of capitalized internal-use software represents the non-cash amortization expense related to our developed technology that is amortized over the estimated useful life.

(10) Gain on investment in equity securities represents an adjustment to the carrying value of the non-marketable security without a readily determinable fair value to reflect observable price changes.

(11) Foreign currency gains and losses include transaction gains and losses incurred in connection with our operations in India.

(12) Loss on transfer of subsidiary represents a loss recognized in connection with the transfer of our subsidiary in India to a third-party and includes impairment charges related to certain assets transferred as part of the agreement, costs incurred to settle certain liabilities arising from the agreement, and one-time legal costs incurred to facilitate the transaction.

(13) Per share impact of non-GAAP expenses represents the per share impact of aggregated non-GAAP items included in (1) through (12)

Investor Relations

Sasha Kipkalov

[email protected]

Media

[email protected]

Source: Blend

Categories

Business Wire Press Releases

Next Articles